BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9824785)

  • 1. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Wuermser LA; Poindexter J; Pak CY
    J Clin Pharmacol; 1998 Nov; 38(11):1035-41. PubMed ID: 9824785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
    Wuermser LA; Reilly C; Poindexter JR; Sakhaee K; Pak CY
    Kidney Int; 2000 Feb; 57(2):607-12. PubMed ID: 10652038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
    Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Pak CY
    Am J Kidney Dis; 1999 Jul; 34(1):107-13. PubMed ID: 10401023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials.
    Pak CY
    Clin Nephrol; 2000 Oct; 54(4):271-5. PubMed ID: 11076102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
    Odvina CV; Mason RP; Pak CY
    Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis.
    Odvina CV; Preminger GM; Lindberg JS; Moe OW; Pak CY
    Kidney Int; 2003 Jan; 63(1):240-7. PubMed ID: 12472789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of potassium chloride or triamterene in thiazide hypokalemia.
    Papademetriou V; Burris J; Kukich S; Freis ED
    Arch Intern Med; 1985 Nov; 145(11):1986-90. PubMed ID: 3904654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ; Peterson R; Pak CY
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
    Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
    J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
    Koenig K; Padalino P; Alexandrides G; Pak CY
    J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazide treatment of systemic hypertension: effects on serum magnesium and ventricular ectopic activity.
    Hollifield JW
    Am J Cardiol; 1989 Apr; 63(14):22G-25G. PubMed ID: 2705372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of potassium-magnesium citrate on upper gastrointestinal mucosa.
    Gonzalez GB; Pak CY; Adams-Huet B; Taylor R; Bilhartz LE
    Aliment Pharmacol Ther; 1998 Jan; 12(1):105-10. PubMed ID: 9692708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
    Kohvakka A
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium.
    Helderman JH; Elahi D; Andersen DK; Raizes GS; Tobin JD; Shocken D; Andres R
    Diabetes; 1983 Feb; 32(2):106-11. PubMed ID: 6337892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum potassium testing in diuretic-treated outpatients. A multivariate approach.
    Tierney WM; McDonald CJ; McCabe G
    Med Decis Making; 1985; 5(1):89-104. PubMed ID: 4068936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium/magnesium depletion in patients with cardiovascular disease.
    Dyckner T; Wester PO
    Am J Med; 1987 Mar; 82(3A):11-7. PubMed ID: 3565422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.